Compare DRS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRS | RVTY |
|---|---|---|
| Founded | 1969 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 11.6B |
| IPO Year | 2021 | 1994 |
| Metric | DRS | RVTY |
|---|---|---|
| Price | $43.72 | $113.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 16 |
| Target Price | $49.33 | ★ $109.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.91% | 0.34% |
| EPS Growth | ★ 28.75 | N/A |
| EPS | 0.23 | ★ 0.36 |
| Revenue | ★ $3,648,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $8.14 | $6.37 |
| Revenue Next Year | $6.54 | $5.10 |
| P/E Ratio | ★ $189.80 | $315.43 |
| Revenue Growth | ★ 12.80 | N/A |
| 52 Week Low | $32.43 | $81.22 |
| 52 Week High | $50.59 | $118.30 |
| Indicator | DRS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 68.33 |
| Support Level | $42.77 | $95.31 |
| Resistance Level | $47.20 | $118.30 |
| Average True Range (ATR) | 1.82 | 3.88 |
| MACD | -0.47 | 1.03 |
| Stochastic Oscillator | 32.58 | 87.57 |
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. It is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.